INR Calculator - International Normalized Ratio
Enter your prothrombin time (PT) result, the lab control PT, and the ISI value from your reagent to calculate your International Normalized Ratio (INR). The calculator shows your result, its bleeding-risk category, and whether you are within the therapeutic target for your clinical indication. Results update as you type.
Formula
Worked example
Patient PT = 24 s, control PT = 12 s, ISI = 1.3. PT ratio = 24 / 12 = 2.0. INR = 2.0 ^ 1.3 = 2.46. This falls within the 2.0-3.0 therapeutic range for atrial fibrillation.
What is INR and why does it matter?
The International Normalized Ratio (INR) is a standardized measure of how long your blood takes to clot. It is derived from the Prothrombin Time (PT) test, which measures the speed of the extrinsic and common coagulation pathways - the cascade that ultimately converts fibrinogen into a stable clot. Before INR was introduced, PT results varied widely between laboratories because different thromboplastin reagents had different sensitivities. INR corrects for this by applying an ISI (International Sensitivity Index) calibration factor, so a patient measured at any laboratory worldwide gets a comparable result. INR is used primarily to monitor warfarin (Coumadin) therapy, assess bleeding risk before surgery, and evaluate liver function, since the liver makes the clotting factors INR depends on.
How INR is calculated
The formula is INR = (Patient PT / Control PT) raised to the power of ISI. The patient PT is the clotting time measured from your blood sample. The control PT is the mean normal clotting time established by your local laboratory, usually 11-14 seconds. The ISI is a reagent-specific calibration constant supplied by the thromboplastin manufacturer; a perfectly calibrated reagent has an ISI of 1.0, and most modern reagents fall between 0.9 and 1.7. A higher ISI means the reagent is less sensitive, and the exponent pushes the INR higher relative to the raw PT ratio. Because the ISI is built into every INR result, you can compare readings taken at different hospitals or on different analyzers with confidence.
Interpreting your INR result
For healthy adults not taking anticoagulants, a normal INR is roughly 0.8-1.1. Values above 1.1 suggest some degree of coagulation impairment: liver disease, vitamin K deficiency, a congenital factor deficiency, or warfarin therapy. The therapeutic window for most warfarin patients is 2.0-3.0. Within this range, the risk of stroke or thromboembolism is substantially reduced while keeping major bleeding risk acceptable. Patients with mechanical heart valves or antiphospholipid syndrome often require a higher target of 2.5-3.5 because of the greater thrombotic risk those conditions carry. An INR above 3.5 raises bleeding risk noticeably; values above 5.0 are associated with serious spontaneous bleeding and usually require dose interruption, vitamin K supplementation, or in emergencies, clotting factor reversal.
Warfarin monitoring and dose adjustment
Warfarin takes 3-5 days to reach a new steady state after any dose change, because it inhibits the synthesis of new clotting factors rather than inactivating existing ones. INR is therefore checked frequently when starting therapy or after a dose adjustment, then at intervals of 4-12 weeks once stable. Many factors shift the INR outside the target window: changes in dietary vitamin K intake (green leafy vegetables are rich sources), starting or stopping other medications, illness, alcohol intake, and genetic variation in warfarin metabolism (CYP2C9) and sensitivity (VKORC1). Anticoagulation clinics use INR trends - not single readings - to make dose decisions, and they track time-in-therapeutic-range (TTR) as an overall quality measure.
INR therapeutic target ranges by clinical indication
| Clinical indication | Target INR range |
|---|---|
| No anticoagulation (healthy adult) | 0.8 - 1.1 |
| Atrial fibrillation | 2.0 - 3.0 |
| DVT / pulmonary embolism (VTE treatment) | 2.0 - 3.0 |
| Mechanical heart valve (low-risk position) | 2.5 - 3.5 |
| Mechanical heart valve (high-risk position) | 2.5 - 3.5 |
| Antiphospholipid syndrome | 2.5 - 3.5 |
| Pre-procedure safety threshold | < 1.5 |
| Supratherapeutic - dose review needed | > 3.5 |
| High bleeding risk - hold / reverse | > 5.0 |
Standard targets used in anticoagulation management. Individual patient targets may differ - always follow your prescriber's instructions.
Frequently asked questions
What is a normal INR?
For people not taking anticoagulants, a normal INR is approximately 0.8-1.1. Values above 1.1 may indicate liver disease, vitamin K deficiency, a coagulation factor problem, or warfarin therapy. An INR below 0.8 is rarely clinically significant but can be seen with very high vitamin K intake.
What INR is needed for warfarin therapy?
For the majority of conditions managed with warfarin (atrial fibrillation, DVT, pulmonary embolism), the target range is 2.0-3.0. Patients with mechanical heart valves or antiphospholipid syndrome usually target 2.5-3.5. Your prescriber sets your individual target based on your specific indication and bleeding risk, so always follow their guidance.
What happens if my INR is too high?
An elevated INR means your blood takes longer to clot than expected, raising the risk of unwanted bleeding. Mild elevations (3.5-5.0) are typically managed by temporarily holding warfarin doses and rechecking in a few days. Levels above 5.0 may require vitamin K supplementation to reverse the effect; levels above 8-10 with active bleeding are a medical emergency requiring clotting factor concentrates or fresh frozen plasma.
What happens if my INR is too low?
A low INR (below your therapeutic target) means your blood clots faster than desired, leaving you under-protected against the clot or stroke that warfarin is prescribed to prevent. Your doctor or anticoagulation nurse may increase your warfarin dose or ask you to return sooner for a repeat test. Never increase your dose without instruction.
What is ISI and where do I find it?
The International Sensitivity Index (ISI) is a calibration factor specific to the thromboplastin reagent and analyzer your laboratory uses. It is assigned by the reagent manufacturer and typically falls between 0.9 and 1.7. Most laboratories report INR directly on your result sheet rather than requiring you to calculate it yourself, but if you have the raw PT values and the ISI, you can use this calculator to verify or reproduce the result.
Can INR be used to monitor direct oral anticoagulants (DOACs)?
No. INR is specific to the vitamin K antagonist warfarin. Drugs such as apixaban, rivaroxaban, dabigatran, and edoxaban work through different mechanisms and do not reliably elevate the PT/INR, so standard INR monitoring does not apply to them. DOACs are typically monitored by drug-specific anti-Xa or thrombin inhibitor assays when monitoring is required.
How do foods affect my INR?
Warfarin works by blocking vitamin K recycling in the liver. Foods rich in vitamin K, especially green leafy vegetables such as spinach, kale, broccoli, and Brussels sprouts, can blunt warfarin's effect and lower your INR. Sudden large changes in vitamin K intake cause the most instability. The general advice is to keep your vitamin K intake consistent rather than avoiding these foods entirely, and to tell your anticoagulation team when your diet changes significantly.
Sources
- World Health Organization. WHO Expert Committee on Biological Standardization: Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy.
- Ageno W, et al. Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. CHEST Guidelines. American College of Chest Physicians, 2012.